A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

BACKGROUND: Intermediate-stage hepatocellular carcinoma (HCC), defined according to the Barcelona Clinic Liver Cancer (BCLC) staging system, is a heterogeneous condition with variable clinical benefits from transarterial chemoembolization (TACE). This study aimed to develop a simple validated progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogasawara, Sadahisa, Chiba, Tetsuhiro, Ooka, Yoshihiko, Kanogawa, Naoya, Motoyama, Tenyu, Suzuki, Eiichiro, Tawada, Akinobu, Azemoto, Ryosaku, Shinozaki, Masami, Yoshikawa, Masaharu, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412579/
https://www.ncbi.nlm.nih.gov/pubmed/25919025
http://dx.doi.org/10.1371/journal.pone.0125244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412579/
https://www.ncbi.nlm.nih.gov/pubmed/25919025
http://dx.doi.org/10.1371/journal.pone.0125244

Ejemplares similares